Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.

Proglucagon-derived glucagon-like peptide-2 (GLP-2) is liberated in enteroendocrine cells and neurons. GLP-2 regulates energy absorption and epithelial integrity in the gastrointestinal tract, whereas GLP-2 action in the central nervous system remains poorly defined. We identified proglucagon and GLP-2 receptor (GLP-2R) mRNA transcripts by RT-PCR in multiple regions of the developing and adult rat central nervous system. GLP-2R mRNA transcripts were localized by in situ hybridization to the hippocampus, hypothalamus, nucleus of the solitary tract, parabrachial nucleus, supramammillary nucleus, and substantia nigra. The bioactive form of GLP-2, GLP-2-(1-33) was detected by RIA and HPLC analysis in the fetal and adult brainstem and hypothalamus. GLP-2 stimulated increases in cAMP accumulation in postnatal d 8, but not embryonic d 14, dispersed neonatal rat brainstem tissues. The actions of GLP-2 were independent of the GLP-1R antagonist exendin-(9-39), and GLP-2 stimulated cAMP accumulation in hippocampal cell cultures from both wild-type and GLP-1R(-/-) mice. GLP-2 significantly reduced glutamate-induced excitotoxic injury in hippocampal cells via a protein kinase A-dependent pathway, but had no effect on the rate of cell proliferation. These findings establish the presence of a functional GLP-2-GLP-2R axis in the developing rodent brain and demonstrate that GLP-2 exerts cytoprotective actions in cells derived from the central nervous system.

[1]  J. Holst,et al.  Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety , 2003, Regulatory Peptides.

[2]  W. Banks,et al.  Glucagon-like peptide-1 receptor is involved in learning and neuroprotection , 2003, Nature Medicine.

[3]  J. M. Ruiz-Albusac,et al.  Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes. , 2003, European journal of biochemistry.

[4]  M. Mattson,et al.  Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron , 2003 .

[5]  D. Drucker,et al.  Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites , 2003, The Journal of Neuroscience.

[6]  A. Astrup,et al.  No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects† , 2003, International Journal of Obesity.

[7]  D. Drucker.  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[8]  R. Seeley,et al.  The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness , 2002, The Journal of Neuroscience.

[9]  P. MacDonald,et al.  Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K(+) currents in beta-cells: a possible glucose-dependent insulinotropic mechanism. , 2002, Diabetes.

[10]  M. Mattson,et al.  Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[11]  B. Yusta,et al.  Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase* , 2002, The Journal of Biological Chemistry.

[12]  S. Said,et al.  Vasoactive intestinal peptide attenuates cytochrome c translocation, and apoptosis, in rat hippocampal stem cells , 2002, Neuroscience Letters.

[13]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[15]  B. Yusta,et al.  Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[16]  D. Drucker,et al.  Minireview: the glucagon-like peptides. , 2001, Endocrinology.

[17]  J. Holst,et al.  GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[18]  B. Yusta,et al.  The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway* , 2000, The Journal of Biological Chemistry.

[19]  B. Yusta,et al.  Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. , 2000, Endocrinology.

[20]  B. Yusta,et al.  Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. , 2000, Gastroenterology.

[21]  P. J. Larsen,et al.  The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake , 2000, Nature Medicine.

[22]  S. Woods,et al.  The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride , 2000, The Journal of Neuroscience.

[23]  D. Drucker,et al.  Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling1. , 2000, Endocrinology.

[24]  B. Yusta,et al.  Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. , 1999, The American journal of physiology.

[25]  E. Blázquez,et al.  Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[26]  L. Rinaman.  Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. , 1999, American Journal of Physiology.

[27]  D. Drucker,et al.  Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. , 1999, Gastroenterology.

[28]  D. Drucker.  Glucagon-like Peptide 2 , 1999, Trends in Endocrinology & Metabolism.

[29]  D. Drucker,et al.  Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Shughrue,et al.  Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system , 1999, The Journal of comparative neurology.

[31]  D. Drucker,et al.  Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. , 1997, The American journal of physiology.

[32]  P. J. Larsen,et al.  Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem , 1997, Neuroscience.

[33]  E. Blázquez,et al.  Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats , 1996, Regulatory Peptides.

[34]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[35]  I. Merchenthaler,et al.  Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. , 1996, Endocrinology.

[36]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[37]  N. Seidah,et al.  Role of prohormone convertases in the tissue-specific processing of proglucagon. , 1996, Molecular endocrinology.

[38]  S. Bloom,et al.  A role for central glucagon‐like peptide‐1 in temperature regulation , 1996, Neuroreport.

[39]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[40]  D. Drucker,et al.  Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. , 1994, Endocrinology.

[41]  J. H. Dierendonck,et al.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  P. Brubaker,et al.  Control of proglucagon-derived peptide synthesis and secretion in fetal rat hypothalamus. , 1992, Neuroendocrinology.

[43]  D. Drucker,et al.  Developmental and tissue-specific regulation of proglucagon gene expression. , 1990, Endocrinology.

[44]  S. Bloom,et al.  Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.

[45]  L. Swanson,et al.  A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radi , 1989 .

[46]  P. Blache,et al.  Oxyntomodulin and glicentin: brain-gut peptides in the rat. , 1988, Endocrinology.

[47]  D. Drucker,et al.  Glucagon gene expression in vertebrate brain. , 1988, The Journal of biological chemistry.

[48]  J. Lauder,et al.  Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.

[49]  L. Orci,et al.  Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.

[50]  H. Zingg,et al.  Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. , 1982, The Journal of clinical investigation.

[51]  C. Saper,et al.  Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.

[52]  N. Greig,et al.  The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.

[53]  B. Yusta,et al.  Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. , 2001, Cancer research.

[54]  D. Drucker,et al.  Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling* , 1999 .

[55]  D. Drucker,et al.  Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro. , 1990, Endocrinology.

[56]  V. Han,et al.  Cellular localization of proglucagon/glucagon‐like peptide I messenger RNAs in rat brain , 1986, Journal of neuroscience research.